Parents who advised daughter (23) against chemotherapy warned over behaviour in court
Paloma Shemirani (23) collapsed on July 19th last year and was taken to Royal Sussex County Hospital in Brighton, England, where she died five days later. She had earlier declined treatment for non-Hodgkin lymphoma.
Advertisement
Her mother, Kay 'Kate' Shemirani, a prominent online conspiracy theorist and her father, Dr Faramarz Shemirani, who is 'sympathetic' to his ex-wife's views, believe medical professionals are to blame for their daughter's death.
Coroner Catherine Wood, presiding over the inquest at Kent and Medway Coroner's Court in Maidstone, left the court due to the behaviour of Miss Shemirani's parents on Tuesday afternoon.
Faramarz Shemirani outside the inquest. Photo: PA
The inquest, which was originally scheduled to conclude on Wednesday, had been extended as the evidence and questioning of witnesses had taken longer than anticipated.
On Tuesday, Mrs Shemirani, who was struck off as a nurse in 2021 after spreading harmful misinformation about Covid-19, was cross-examined by Dr Shemirani.
Advertisement
Questioning broke down when Dr Shemirani, who is understood to have a PhD in computational fluid dynamics, tried to ask his ex-wife's opinion of medical evidence which she would then try to answer, despite warnings from the coroner.
'Mrs Shemirani, I've told you not to speak, I'll find you in contempt if you keep on speaking now,' the coroner said.
'Confine [yourself] to asking questions of this witness as a witness of fact,' she told Dr Shemirani.
As Dr Shemirani argued back through his video-link, the coroner said: 'Dr Shemirani, challenge me by judicial review later' before trying to move on.
Advertisement
'Of course I will, of course I will,' he replied.
Later, Dr Shemirani once again tried to ask questions which had already been ruled irrelevant by the coroner.
'I'm going to rise for a few minutes because I'm finding it incredibly difficult to keep you on track,' said Ms Wood.
Dr Shemirani continued to speak until the coroner shouted 'Dr Shemirani, listen'.
Advertisement
'Your behaviour has been bordering on contemptuous to the court – when I make a ruling on something you cannot come back,' she added.
Mrs Shemirani also accused osteopath Nick Gosset of lying under oath earlier in the inquest.
Mr Gosset treated Miss Shemirani the day she collapsed and said she had appeared to be in the 'last stages of a very difficult disease'.
He told the court that when he inspected her, he could feel lumps in her right shoulder going all the way up into her neck, which he identified as lymphoid mass and that he 'had never seen anything like it' in 43 years of practice.
Advertisement
Mr Gosset told the court: 'It was obvious to me that I was not the right person to be helping her, normally you see a patient like that, you would refer her [to a GP].
'Any referral was refused – when I suggested that the proper avenue of approach was through a normal, medical channel she dismissed it.
On Tuesday, Paloma's mother said 'his statement under oath is completely opposed with the truth' and has argued her daughter was healthy the day she collapsed.
The inquest continues on Wednesday.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 hours ago
- The Independent
Over-50s provided more donated organs than ever before last year, data shows
The highest-ever proportion of organ donors in the UK last year were over the age of 50, according to officials. However, only one in four people on the organ donation register are 50 or over, NHS Blood and Transplant (NHSBT) said. NHSBT analysis found there were 932 donors aged above 50 last year, making up 63% of all people who donated organs after death – the highest-ever proportion. It is now calling for more people in the age group to sign the NHS Organ Donor Register. Anthony Clarkson, director for organ and tissue donation and transplantation at NHSBT, said: 'We know from research many people aged over 50 mistakenly think they're too old to donate or that their health might stop them donating. 'However, more and more research shows that organs from older donors are lifesaving. 'The reality is the over-50s are more important to organ donation than ever. There is no age limit to organ and tissue donation, and people die every day waiting for a transplant.' According to NHSBT, the rise could be down to the ageing population, public awareness of organ donation, new techniques and more research which shows that organs from older donors can be successfully used. Nick Beresford, from London, became an organ donor at 57. He was working as the resident representative of the United Nations Development Programme in Georgia in July 2023 when he had a brain haemorrhage. His kidneys and liver were donated and transplanted into three recipients: a man in his fifties, a woman in her sixties, and another woman in her fifties. Mr Beresford's wife Angela, 51, a pilates instructor, said: 'Nick spent his whole life helping people living in extreme poverty, people with disabilities and the marginalised. He was a truly good and generous man. He was a fantastic dad and the love of my life. 'Being a donor gives others that chance, that's probably the most beautiful thing a person can do. 'I would definitely encourage other people over 50 to join the NHS Organ Donor Register – you could still save lives if something happens.' Margaret Humphries, from Richmond in London, also donated both kidneys after a brain haemorrhage aged 65. Husband John, a retired manager, said: 'My darling wife was a very giving person. Margaret's two children from her first marriage and I all agreed that donation was the right decision. 'Margaret was an absolute angel. It was very fitting that her last action would be to save somebody else.' Mr Clarkson added: 'Your organs don't need to be the same as when you in your 20s – if someone will die without a transplant, a healthy organ from someone over 50 will be a lifesaver.'
The Independent
2 hours ago
- The Independent
Experts warn that progress in cancer survival rates is ‘slowing'
Progress in cancer survival rates across the UK has "slowed down", experts have warned, as a new study reveals the disparity in outcomes between the most and least deadly forms of the disease is wider than ever before. Researchers are now calling for a national cancer plan, deeming it "essential" to "bring cancer survival trends back towards the best in the world". The comprehensive study, led by the London School of Hygiene and Tropical Medicine (LSHTM) and funded by Cancer Research UK, meticulously analysed long-term trends in the cancer survival index (CSI) for adults across England and Wales. Covering the period from 1971 to 2018, the research utilised records from the National Disease Registration Service for England and the Welsh Cancer Intelligence and Surveillance Unit, estimating net survival for up to 10 years after diagnosis for approximately 10.8 million people. In 2018, the CSI for all cancers combined a decade after diagnosis stood at 49.8 per cent – a figure hailed as "remarkable" by researchers, surpassing the one-year CSI for those diagnosed in 1971/72. However, the study highlighted a concerning trend: the "speed of improvement in survival has slowed down". Between 2000/01 and 2005/06, the 10-year CSI saw a 4 per cent rise, from 41.2 per cent to 45.2 per cent. Yet, in the subsequent period from 2010/11 to 2015/16, this increase dwindled to just 1.4 per cent, reaching 49.3 per cent. Significant disparities in survival rates were also identified across different cancer types. For instance, 10-year survival for testicular cancer was 97 per cent, starkly contrasting with just 4.3 per cent for pancreatic cancer. While screening programmes have bolstered survival rates for breast, bowel, and cervical cancers, progress for other types, including stomach, lung, and brain cancer, has seen only marginal increases over the past five decades. Writing in the Lancet Regional Health – Europe, the researchers concluded that this slowdown for individual cancers implied a "system-wide challenge". Michelle Mitchell, chief executive of Cancer Research UK, commented: "Thanks to research, most patients today are far more likely to survive their cancer than at any point in the past. But the reality is that this progress is slowing – and for some cancers, it never got going in the first place." Michel Coleman, a professor of epidemiology and statistics at LSHTM, underscored the urgency: "Since I began my career in cancer research, I've seen substantial increases in survival for most types of cancer. Our understanding of cancer biology has expanded, effective screening programmes have been introduced, and new treatments have been developed. Allowing this trend to stall will have devastating consequences." He added: "This study was only possible because of data on millions of patients from cancer registries in England and Wales. It's vital that the Government provides the political and financial support to ensure we maintain this crucial data. Without these, the Government will be flying blind on cancer control. The National Cancer Plan is a chance to improve NHS cancer pathways and reap the benefits of new research – the Government must take it." Cancer Research UK is advocating for the national cancer plan to address unacceptable delays by slashing waiting times for diagnosis and treatment. They also call for improved early diagnosis, boosted participation in existing screening programmes, and a commitment to fully rolling out lung cancer screening in England by 2029. The Government launched a call for evidence in February to help shape a national cancer plan, aiming to outline actions to transform disease treatment and reduce deaths. A Department of Health and Social Care spokesperson stated: "We are prioritising cancer care as we turn around more than a decade of neglect of our NHS. We're already seeing progress, with 95,000 more people having cancer diagnosed or ruled out within 28 days between July 2024 and May 2025, compared to the same period the previous year. The National Cancer Plan will set out how we will improve survival rates further and address the variation between different cancer types."
The Independent
2 hours ago
- The Independent
Speed of improvement in cancer survival rates ‘slowing', say experts
Progress in cancer survival rates in the UK has 'slowed down', experts have warned. The news comes as a study suggests survival between the most and least deadly types of the disease is wider than ever before. A national cancer plan was 'essential' to 'bring cancer survival trends back towards the best in the world', researchers said. The study, led by the London School of Hygiene and Tropical Medicine (LSHTM) and funded by Cancer Research UK, analysed long-term trends in the cancer survival index (CSI) for adults across England and Wales from 1971 to 2018. Using records from the National Disease Registration Service for England and the Welsh Cancer Intelligence and Surveillance Unit, experts estimated net survival for up to 10 years after diagnosis for around 10.8 million people. They found that in 2018, the CSI for all cancers combined a decade after diagnosis was 49.8%, higher than the CSI at one year for those diagnosed in 1971/72. Researchers hailed the figure as 'remarkable', but warned that the 'speed of improvement in survival has slowed down'. In the five years from 2000/01 to 2005/06, the 10-year CSI rose by 4%, from 41.2% to 45.2%. But between 2010/11 and 2015/16, the rise was 1.4%, from 47.9% to 49.3%. There were also major gaps in survival when it came to different cancer types. For example, 10-year survival for testicular cancer was 97%, compared with 4.3% for pancreatic cancer. Screening programmes had bolstered survival rates for cancers in the breast, bowel and cervix, according to Cancer Research UK. But survival for other types, such as stomach, lung and brain cancer, had increased by only a small amount in the past 50 years. Writing in the Lancet Regional Health – Europe, researchers warned this slowdown for individual cancers implied a 'system-wide challenge'. Michelle Mitchell, chief executive of Cancer Research UK, said: 'Thanks to research, most patients today are far more likely to survive their cancer than at any point in the past. 'But the reality is that this progress is slowing – and for some cancers, it never got going in the first place.' The Government launched a call for evidence to help shape a national cancer plan in February. The blueprint aims to outline actions to transform how the disease is treated in a bid to reduce deaths. Ms Mitchell said: 'The upcoming National Cancer Plan for England must include commitments to spot more cancers earlier, as well as backing research into new treatments so that each patient, regardless of their diagnosis, can hope for more moments with the people they love.' Michel Coleman, a professor of epidemiology and statistics at LSHTM, said: 'Since I began my career in cancer research, I've seen substantial increases in survival for most types of cancer. 'Our understanding of cancer biology has expanded, effective screening programmes have been introduced, and new treatments have been developed. Allowing this trend to stall will have devastating consequences. 'This study was only possible because of data on millions of patients from cancer registries in England and Wales. 'It's vital that the Government provides the political and financial support to ensure we maintain this crucial data. Without these, the Government will be flying blind on cancer control. 'The National Cancer Plan is a chance to improve NHS cancer pathways and reap the benefits of new research – the Government must take it.' Cancer Research UK is calling for the national cancer plan to slash waiting times for diagnosis and treatment, saying some patients face unacceptable delays. The plan should also improve early diagnosis of cancer, with plans to boost participation in existing screening programmes and a commitment to rolling out lung cancer screening fully in England by 2029. A Department of Health and Social Care spokesperson said: 'We are prioritising cancer care as we turn around more than a decade of neglect of our NHS. 'We're already seeing progress, with 95,000 more people having cancer diagnosed or ruled out within 28 days between July 2024 and May 2025, compared to the same period the previous year. 'The National Cancer Plan will set out how we will improve survival rates further and address the variation between different cancer types.'
